EchoSolv AS vs HeartFlow Analysis
AI Verdict
Choose EchoSolv AS if…
Choose EchoSolv AS if your primary need is to rapidly and accurately identify patients at high risk for severe aortic stenosis using existing echocardiogram measurements. This tool is ideal for cardiology departments seeking AI-powered clinical decision support to prioritize studies for closer review and enhance the efficiency of sAS risk detection within current PACS workflows.
View EchoSolv AS →Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a comprehensive, non-invasive diagnostic solution for coronary artery disease (CAD) based on standard CT scans. This tool is best suited for clinicians who need personalized 3D models of coronary arteries, FFRct analysis, and plaque characterization to guide management strategies and treatment decisions for CAD patients.
View HeartFlow Analysis →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | HeartFlow Analysis |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing |
| Deployment | Cloud-based | Cloud-based (AWS) |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoSolv ASEchoSolv AS is designed for minimal workflow disruption, explicitly stating 'no EMR integration required' and 'integrates with PACS,' alongside ultra-fast risk detection in under 3 seconds. This indicates a simpler and quicker integration process compared to HeartFlow Analysis, which, while offering EMR integration, implies a more involved setup for its 3D modeling capabilities.
Clinical Value
HeartFlow AnalysisBoth tools are FDA-cleared and offer high diagnostic accuracy for critical cardiac conditions. However, HeartFlow Analysis provides a comprehensive non-invasive diagnostic pathway for Coronary Artery Disease (CAD) through FFRct and Plaque Analysis, potentially reducing the need for invasive procedures. This capability to avoid invasive interventions offers a significant advantage in patient safety and cost reduction.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis clearly outlines a fee-for-service model with established Category I CPT codes for its FFRct and AI-Enabled Quantitative Plaque Analysis, and states coverage by Medicare and most U.S. commercial payers. This transparency and established reimbursement pathway offer clear financial value and ease of adoption for healthcare providers. EchoSolv AS, while working on reimbursement, does not provide comparable details on established codes or coverage.
Enterprise Readiness
HeartFlow AnalysisBoth tools are cloud-based, HIPAA compliant, have BAA, and FDA cleared, with EchoSolv AS also being SOC 2 Type II certified. However, HeartFlow Analysis demonstrates broader enterprise readiness through its established reimbursement codes, commercial availability across multiple regions (US, Europe, Japan, Canada), and comprehensive support for integration with PACS and EMR systems.
Innovation
HeartFlow AnalysisWhile EchoSolv AS innovates by providing measurement-based AI for severe aortic stenosis detection without image analysis, HeartFlow Analysis exhibits a higher degree of technological innovation. It leverages AI for complex 3D modeling of coronary arteries, computational fluid dynamics (CFD) for blood flow simulation, and FFRct analysis, offering a more transformative, non-invasive diagnostic approach to coronary artery disease.
Support & Docs
HeartFlow AnalysisHeartFlow offers extensive support, including billing and reimbursement assistance, technical integration with PACS/EMR, educational materials, peer-to-peer education, and a dedicated clinical and technical support team. EchoSolv AS mentions general feedback and support channels and a user manual, but lacks the detailed breadth of comprehensive support described by HeartFlow.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | HeartFlow Analysis |
|---|---|---|
| Name | EchoSolv AS | HeartFlow Analysis |
| Company | Echo IQ | HeartFlow |
| Description | EchoSolv AS is an FDA-cleared, AI-powered clinical decision support platform by Echo IQ that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows. | HeartFlow Analysis is a commercial-stage medical technology company providing software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. |
| Primary Clinical Focus | Severe Aortic Stenosis (sAS) | Coronary Artery Disease (CAD) |
| Input Data Type | Echocardiogram measurements | Standard CT scans |
| Key Feature Example | AI-powered clinical decision support for severe aortic stenosis probability | AI-powered 3D modeling of coronary arteries |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and HeartFlow Analysis.